2024

Poster

Targeting squalene epoxidase for breast cancer brain metastasis: the evolution of a new therapeutic target for brain extravasation and colonization using animal models

2023

Poster

PXB-mice with humanized livers provide better predictions of human pharmacokinetics compared to CB17-SCID mice

Poster

Reshaping the tumor microenvironment: new application of tamoxifen in triple negative breast cancer immunomodulation

Poster

Targeting squalene epoxidase in breast-to-brain metastasis: A new therapeutic target for brain extravasation and colonization using animal models

2022

Poster

Murine Vaginal Infection Models with MDR Neisseria gonorrhoeae Isolates for Pharmacology Studies

Webinar

In vitro NASH Panels and in vivo NASH models for NASH drug discovery

Webinar

Komabiotech Webinar - In vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)

Webinar

Eurofins Discovery Safety Pharmacology Portfolio

2021

Mini Webinar

Nerve Injury Induced Neuropathic Pain Models in Rodents

2020

FDA Workshop - Advancing Animal Models for Antibacterial Drug Development

Development of a Murine Model of Pseudomonas aeruginosa Lung Infection

2019

ASM/ESCMID

Establishment of Murine Thigh Infection Models with Clinical Isolates of MDR Klebsiella pneumoniae for Pharmacological Studies

2018

ASM/ESCMID

A Panel of MDR P. aeruginosa Clinical Isolates for Pharmacology Studies with Murine Lung and Thigh Infection Models

ASM/ESCMID

Establishment of Murine Thigh and Lung Infection Models with Carbapenem Resistant Clinical Isolates of Pseudomonas aeruginosa

2017

ASM Microbe

Pharmacokinetic-Pharmacodynamic Analyses of Debio 1450 (Afabicin), a Staphylococcal-Specific Antibiotic, Using Data from a Murine-Thigh Infection Model

2016

Advances Against Aspergillosis Conference

Efficacy of CD101, a Novel Echinocandin Antifunal, in a Mouse Model of Disseminated Aspergillosis

ASM Microbe

Prolonged Efficacy Following One Dose of a Novel Echinocandin, CD101, in a Neutropenic Mouse Model of Disseminated Candidiasis

2015

ICC/ICAAC Conference

Prolonged Efficacy Following One Dose of a Novel Echinocandin, CD101, in a Neutropenic Mouse Model of Disseminated Candidiasis

ICC/ICAAC Conference

Novel Echinocandin CD101 Gel Formulation is Highly Effective in Eradicating Candida albicans in a Rat Model of Vulvovaginal Candidiasis